宣泰医药：关于使用部分闲置募集资金进行现金管理的公告

Group 1 - The company announced the approval of a proposal to use part of its idle raised funds for cash management, with a limit not exceeding 80 million RMB [2] - The decision was made during the 15th meeting of the second board of directors' audit committee and the 17th board meeting held on August 8, 2025 [2] - The usage period for the funds is set for 12 months from the date of board approval, allowing for rolling use within the specified limit and timeframe [2]